The same active substances on other registers, the same brand first.
| Pack | Code | Status |
|---|---|---|
| CEFAMANDOLE NAFATE EQ 500MG BASE/VIAL | NDA050504-001 | Discontinued |
| CEFAMANDOLE NAFATE EQ 10GM BASE/VIAL | NDA050504-004 | Discontinued |
| CEFAMANDOLE NAFATE EQ 1GM BASE/VIAL | NDA050504-002 | Discontinued |
| CEFAMANDOLE NAFATE EQ 2GM BASE/VIAL | NDA050504-003 | Discontinued |
| CEFAMANDOLE NAFATE EQ 1GM BASE/VIAL | ANDA062560-001 | Discontinued |
| CEFAMANDOLE NAFATE EQ 2GM BASE/VIAL | ANDA062560-002 | Discontinued |
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
The official texts, at the regulator.
Compiled by Prognia from the public register below; the register’s text is the official one.
Source: U.S. Food and Drug Administration, Drugs@FDA and openFDA drug labels (imported 10 June 2026). Not endorsed by the FDA.
Licence: Public domain (U.S. Government work); openFDA terms · Added 10 Jun 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
